GN0M.XETRA Global X Genomics & Biotechnology UCITS ETF USD Acc

- EUR
No recent price
Total assets
7.05M
Expense ratio
0.52%
Dividend yield
-
1-year return
+50.69%
Holdings
10
Since
2021

Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.

What does GN0M.XETRA invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (90.9%)
  • Largest sector: Healthcare (103.3%)
  • Largest region: North America (95.7%)
  • Top 3 holdings: 25.4% of the fund

Asset allocation

  • US stocks 90.9%
  • Non-US stocks 4.8%
  • Cash 0.2%

Top holdings

All holdings, sectors and regions

Global X Genomics & Biotechnology UCITS ETF USD Acc performance

Sharpe ratio 0.75
This year
+48.32%
1 year
+50.69%
3 years
+24.00%
5 years
0.00%

Volatility 28.0% over 1 year and 29.9% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

GN0M.XETRA price

Prices on the chart can differ slightly from the closing prices StockSummer shows.